LeonaBio (LONA) Cash from Investing Activities (2019 - 2026)

LeonaBio (LONA) has reported Cash from Investing Activities for 8 consecutive years, with -$15.5 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Cash from Investing Activities fell 111.4% year-over-year to -$15.5 million; the TTM figure through Mar 2026 stood at -$24.1 million (down 169.93% YoY), while the FY2025 annual figure was -$15.9 million, down 128.99% from the prior year.
• Cash from Investing Activities declined to -$15.5 million in Q1 2026 per LONA's latest filing, from -$14.6 million in the prior quarter.
• Across five years, Cash from Investing Activities topped out at $35.5 million in Q1 2023 and bottomed at -$15.5 million in Q1 2026.
• Historically, Cash from Investing Activities has averaged $10.4 million across 5 years, with a median of $13.0 million in 2024.
• Annual changes were most pronounced in 2023 — Cash from Investing Activities jumped 828.22% — and 2025, when it tumbled 420.55%.
• LeonaBio's Cash from Investing Activities stood at $24.6 million in 2022, then plunged by 74.07% to $6.4 million in 2023, then sank by 144.0% to -$2.8 million in 2024, then sank by 420.55% to -$14.6 million in 2025, then slipped by 6.16% to -$15.5 million in 2026.
• Business Quant data shows LONA's Cash from Investing Activities at -$15.5 million in Q1 2026, -$14.6 million in Q4 2025, and $5.7 million in Q3 2025.